ImmuneOnco Biopharma is a startup research and development driven company developing immunotherapeutic drugs including bi-specific antibodies and CAR-T cell therapies for all types of cancers including leukemia and solid tumors.
ImmuneOnco Biopharmas primary focus is on tumor immunotherapeutic drugs including checkpoint modulators and target activated NK (TANK) products that will meet the unmet medical needs both in China and global market.